Expansion into the Mexican Pharmaceutical Market

Bombilla con filamento en forma del mapa de México, iluminada en un fondo oscuro.

Mexico stands out as one of the largest economies in Latin America, with a constantly growing pharmaceutical sector and unique opportunities for the introduction of innovative products. Currently, it is the second-largest pharmaceutical market in Latin America, after Brazil, and ranks 12th globally.

The Mexican pharmaceutical market is projected to reach a value of approximately $22.3 billion by 2027, driven by factors such as the prevalence of chronic diseases and increased healthcare spending.

At FullScope Pharma, we guide you through every stage of the process to ensure a successful entry into the Mexican market. We offer a comprehensive approach that includes:

  • Market Analysis: We identify opportunities, assess potential demand, and analyze competitors to strategically position our clients' products.

  • Regulatory Feasibility: We oversee procedures with COFEPRIS and ensure compliance with all local regulations.

  • Tailored Business Models: From licensing to full hosting or strategic partnerships, we design the best strategy to meet each client's specific needs.

With our knowledge and experience, we have successfully helped various portfolios integrate into the dynamic Mexican pharmaceutical ecosystem.